Annual Operating Expenses
$361.99 M
+$11.13 M+3.17%
31 December 2023
Summary:
ImmunityBio annual total operating expenses is currently $361.99 million, with the most recent change of +$11.13 million (+3.17%) on 31 December 2023. During the last 3 years, it has risen by +$30.77 million (+9.29%). IBRX annual operating expenses is now at all-time high.IBRX Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Operating Expenses
$86.36 M
-$14.02 M-13.97%
30 September 2024
Summary:
ImmunityBio quarterly total operating expenses is currently $86.36 million, with the most recent change of -$14.02 million (-13.97%) on 30 September 2024. Over the past year, it has increased by +$1.72 million (+2.03%). IBRX quarterly operating expenses is now -22.85% below its all-time high of $111.94 million, reached on 31 March 2023.IBRX Quarterly Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
IBRX Operating Expenses Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | - | +2.0% |
| 3 y3 years | +9.3% | +8.4% |
| 5 y5 years | +128.4% | - |
IBRX Operating Expenses High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | at high | +71.7% | -22.9% | +9.4% |
| 5 y | 5 years | at high | +128.4% | -22.9% | +134.2% |
| alltime | all time | at high | +128.4% | -22.9% | +134.2% |
ImmunityBio Operating Expenses History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $86.36 M(-14.0%) |
| June 2024 | - | $100.38 M(+5.4%) |
| Mar 2024 | - | $95.24 M(+12.5%) |
| Dec 2023 | $361.99 M(+3.2%) | $84.64 M(+5.5%) |
| Sept 2023 | - | $80.22 M(-5.8%) |
| June 2023 | - | $85.19 M(-23.9%) |
| Mar 2023 | - | $111.94 M(+32.8%) |
| Dec 2022 | $350.86 M | $84.29 M(-7.3%) |
| Sept 2022 | - | $90.92 M(+14.1%) |
| June 2022 | - | $79.66 M(-17.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2022 | - | $95.99 M(+20.5%) |
| Dec 2021 | $331.21 M(+57.1%) | $79.66 M(+1.0%) |
| Sept 2021 | - | $78.90 M(-8.5%) |
| June 2021 | - | $86.25 M(-0.2%) |
| Mar 2021 | - | $86.40 M(+28.5%) |
| Dec 2020 | $210.82 M(+33.1%) | $67.24 M(+21.4%) |
| Sept 2020 | - | $55.37 M(+7.8%) |
| June 2020 | - | $51.35 M(+39.3%) |
| Mar 2020 | - | $36.87 M |
| Dec 2019 | $158.45 M | - |
FAQ
- What is ImmunityBio annual total operating expenses?
- What is the all time high annual operating expenses for ImmunityBio?
- What is ImmunityBio quarterly total operating expenses?
- What is the all time high quarterly operating expenses for ImmunityBio?
- What is ImmunityBio quarterly operating expenses year-on-year change?
What is ImmunityBio annual total operating expenses?
The current annual operating expenses of IBRX is $361.99 M
What is the all time high annual operating expenses for ImmunityBio?
ImmunityBio all-time high annual total operating expenses is $361.99 M
What is ImmunityBio quarterly total operating expenses?
The current quarterly operating expenses of IBRX is $86.36 M
What is the all time high quarterly operating expenses for ImmunityBio?
ImmunityBio all-time high quarterly total operating expenses is $111.94 M
What is ImmunityBio quarterly operating expenses year-on-year change?
Over the past year, IBRX quarterly total operating expenses has changed by +$1.72 M (+2.03%)